title: How should treatment costs impact on physician's decisions?
abstract: This article first discusses at what level of clinical decision making cost considerations may be most pertinent and important. It is argued that cost assessments will be of most relevance and value at an intermediate level of clinical decision making i.e. at a level where so-called policy decisions are made. These are decisions such as which drugs to include in a hospital formulary or which standard treatment 'protocols' to choose for particular types of patients. The personal encounter between individual patients and physicians will take place within the framework of available treatment options determined by these policy decisions, which must necessarily be based on a prior assessment of the expected costs and benefits of treatments. The article goes on to give a brief introduction to the various methods of economic evaluation that have been developed in order to provide the decision makers with the means to make policy decisions on the basis of the most reliable and pertinent information possible.
authors.affiliation: EORTC Health Economics Unit, Brussels, Belgium.
authors.forename: N
authors.initials: N
authors.lastname: Neymark
mesh_terms: D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006291:Health Policy; D006801:Humans; D011050:Policy Making; D010818:Practice Patterns, Physicians' / Q000191:economics*